Guardian Pharmacy Services, Inc. (GRDN) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 3 Buy.
The consensus price target is $36.00 (low: $30.00, high: $40.00), representing a downside of 4.7% from the current price $37.79.
Analysts estimate Earnings Per Share (EPS) of $0.19 and revenue of $1.22B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.41 vs est $0.19 (missed -829.3%). 2025: actual $0.79 vs est $0.98 (missed -19.6%). Analyst accuracy: 31%.
GRDN Stock — 12-Month Price Forecast
$36.00
▼ -4.74% Downside
Average Price Target
Based on 3 Wall Street analysts offering 12-month price targets for Guardian Pharmacy Services, Inc., the average price target is $36.00, with a high forecast of $40.00, and a low forecast of $30.00.
The average price target represents a -4.74% change from the last price of $37.79.
Highest Price Target
$40.00
Average Price Target
$36.00
Lowest Price Target
$30.00
GRDN Analyst Ratings
Buy
Based on 3 analysts giving stock ratings to Guardian Pharmacy Services, Inc. in the past 3 months
EPS Estimates — GRDN
31%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.41
vs Est $0.19
▼ 113.7% off
2025
Actual $0.79
vs Est $0.98
▼ 24.4% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.
Revenue Estimates — GRDN
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.228B
vs Est $1.223B
▲ 0.4% off
2025
Actual $1.449B
vs Est $1.441B
▲ 0.6% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
